JAGLX

Janus Henderson Global Life Sciences Fund Class T [JAGLX] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

JAGLX Stock Summary

Top JAGLX Correlated Resources

JAGLX

Top 10 Correlated ETFs

JAGLX

Top 10 Correlated Stocks

JAGLX

In the News

JAGLX Financial details

Company Rating
-
Market Cap
5.37B
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
0.05
Dividend %
0.07%
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
2.99%
SMA50
4.55%
SMA100
6.15%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
61.61-75.13
52W High
-8.69%
52W Low
+12.26%
RSI
52
Rel Volume
-
Avg Volume
-
Volume
Perf Week
-2.38%
Perf Month
5.13%
Perf Quarter
-0.85%
Perf Half Y
-2.64%
-
-
-
-
Beta
0.73
-
-
Volatility
0.62%, 1.51%
Prev Close
0%
Price
68.48
Change
0%

JAGLX Financial Performance

JAGLX Dividend History

JAGLX Frequently Asked Questions

What is Janus Henderson Global Life Sciences Fund Class T stock symbol ?

Janus Henderson Global Life Sciences Fund Class T is a US stock and trading under the symbol JAGLX

What is Janus Henderson Global Life Sciences Fund Class T stock quote today ?

Janus Henderson Global Life Sciences Fund Class T stock price is $68.48 today.

Is Janus Henderson Global Life Sciences Fund Class T stock public?

Yes, Janus Henderson Global Life Sciences Fund Class T is a publicly traded company.

Something similar

Top by Market Cap
VOO
0YXG.L
AMZN
BRYN.DE
BRK-A
Top Correlated ETFs
VHT
FHLC
IHE
AGNG
BMED
Top Correlated Stocks
FSPHX
SHSCX
SHSKX
SHSSX
SHISX
Similar Market Cap
000881.SZ
ITRI
RADIOCITY.NS
TIVRX
SHUR.BR

Company Profile

Financial Services Asset Management - Global
  • Market Capitalization 5.37B
  • Headquarters US
  • IPO Date 1998-12-31

The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that the portfolio manager believes have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector.